On lighter skin, plaque psoriasis can appear red; on darker skin, it can be purple or grayish. It often goes underdiagnosed and undertreated in the Black community, so it’s important to know ...

but on darker skin types, psoriasis may look dark brown or violet with grayish scales," she adds. Why confidence is key for ...

The following is a summary of “Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients ...

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

These data underscore the promise of next-generation therapies and the potential for icotrokinra to offer adolescents with moderate to severe plaque psoriasis the unique combination of a favorable ...

Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...

In the Phase III ICONIC-LEAD trial, 75% of adolescents with moderate-to-severe plaque psoriasis treated with icotrokinra achieved completely clear skin by week 24. Results from the Phase III ...

Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque ... psoriasis the unique combination of a favorable safety profile and complete skin ...